Perivascular adipose tissue, inflammation and vascular dysfunction in obesity

Current Vascular Pharmacology

Volumn 12, Issue 3, 2014, Pages 403-411

  van de Voorde, Johan ^a   Boydens, Charlotte ^a   Pauwels, Bart ^a   Decaluwé, Kelly ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Adipokines; Atherosclerosis; Blood vessels; Cardiovascular diseases; Hypertension; Obesity; Perivascular adipose tissue; Vascular dysfunction

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ARTERY CONSTRICTION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VESSEL TONE; BROWN ADIPOSE TISSUE; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HYPERTENSION; HYPERTROPHY; INFLAMMATION; MACROPHAGE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RESTENOSIS; VASA VASORUM; VASCULAR DISEASE; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASODILATATION; BLOOD VESSEL; COMPLICATION; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); VASCULAR DISEASES;

ADIPOKINES; ADIPOSE TISSUE; BLOOD VESSELS; HUMANS; MUSCLE, SMOOTH, VASCULAR; OBESITY; VASCULAR DISEASES; VASODILATION;

EID: 84922392173     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161112666140423220628     Document Type: Article

References (100)

1. [1] Szasz T, Webb RC. Perivascular adipose tissue: more than just structural support. Clinical Science 2012; 122(1-2): 1-12.
2. [2] Maenhaut N, Van de Voorde J. Regulation of vascular tone by adipocytes. BMC Med 2011; 9: 25.
3. [3] Boydens C, Maenhaut N, Pauwels B, Decaluwe K, Van de Voorde J. Adipose Tissue as Regulator of Vascular Tone. Curr Hypertens Rep 2012; 14(3): 270-8.
4. [4] Gollasch M. Vasodilator signals from perivascular adipose tissue. Br J Pharmacol 2012; 165(3): 633-42.
5. [5] Aghamohammadzadeh R, Withers S, Lynch F, et al. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target. Br J Pharmacol 2012; 165(3): 670-82.
6. [6] Payne GA, Kohr MC, Tune JD. Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol 2012; 165(3): 659-69.
7. [7] Miao CY, Li ZY. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 2012; 165(3): 643-58.
8. [8] Ouwens DM, Sell H, Greulich S, Eckel J. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 2010; 14(9): 2223-34.
9. [9] Britton KA, Fox CS. Ectopic Fat Depots and Cardiovascular Disease. Circulation 2011; 124(24): E837-E841.
10. [10] Achike FI, To NH, Wang H, Kwan CY. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint. Clin Exp Pharmacol Physiol 2011; 38(1): 1-10.
11. [11] Bays HE. Adiposopathy Is "Sick Fat" a Cardiovascular Disease? J Am Coll Cardiol 2011; 57(25): 2461-73.
12. [12] Hui XY, Lam KSL, Vanhoutte PM, Xu AM. Adiponectin and cardiovascular health: an update. Br J Pharmacol 2012; 165(3): 574-90.
13. [13] Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29(24): 2959-71.
14. [14] Northcott JM, Yeganeh A, Taylor CG, Zahradka P, Wigle JT. Adipokines and the cardiovascular system: mechanisms mediating health and disease. Can J Physiol Pharmacol 2012; 90(8): 1029-59.
15. [15] Yiannikouris F, Gupte M, Putnam K, Cassis L. Adipokines and blood pressure control. Curr Opin Nephrol Hypertens 2010; 19(2): 195-200.
16. [16] Ouchi N, Ohashi K, Shibata R, Murohara T. Adipocytokines and Obesity-Linked Disorders. Nagoya J Med Sci 2012; 74(1-2): 19-30.
17. [17] Eringa EC, Bakker W, van Hinsbergh VWM. Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vascul Pharmacol 2012; 56(5-6): 204-9.
18. [18] Rajsheker S, Manka D, Blomkalns AL, et al. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 2010; 10(2): 191-6.
19. [19] Falcao-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenco AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 2012; 17(15-16): 880-9.
20. [20] Lehr S, Hartwig S, Sell H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl 2012; 6(1-2): 91-101.
21. [21] Chang L, Villacorta L, Li RX, et al. Loss of Perivascular Adipose Tissue on Peroxisome Proliferator-Activated Receptor-gamma Deletion in Smooth Muscle Cells Impairs Intravascular Thermoregulation and Enhances Atherosclerosis. Circulation 2012; 126(9): 1067-78.
22. [22] Chatterjee TK, Stoll LL, Denning GM, et al. Proinflammatory Phenotype of Perivascular Adipocytes Influence of High-Fat Feeding. Circ Res 2009; 104(4): 541-9.
23. [23] Takemori K, Gao YJ, Ding L, et al. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007; 49(2): 365-72.
24. [24] Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. Obesity Promotes Inflammation in Periaortic Adipose Tissue and Angiotensin II-Induced Abdominal Aortic Aneurysm Formation. Arterioscler Thromb Vasc Biol 2009; 29(10): 1458-64.
25. [25] Galvez-Prieto B, Bolbrinker J, Stucchi P, et al. Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol 2008; 197(1): 55-64.
26. [26] Gao YJ. Dual modulation of vascular function by perivascular adipose tissue and its potential correlation with adiposity/lipoatrophyrelated vascular dysfunction. Curr Pharm Des 2007; 13(21): 2185-92.
27. [27] Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R. Perivascular adipose tissue as a messenger of the brain-vessel axis: Role in vascular inflammation and dysfunction. J Physiol Pharmacol 2007; 58(4): 591-610.
28. [28] Frontini A, Cinti S. Distribution and Development of Brown Adipocytes in the Murine and Human Adipose Organ. Cell Metab 2010; 11(4): 253-6.
29. [29] Sacks HS, Fain JN, Holman B, et al. Uncoupling Protein-1 and Related Messenger Ribonucleic Acids in Human Epicardial and Other Adipose Tissues: Epicardial Fat Functioning as Brown Fat. J Clin Endocrinol Metab 2009; 94(9): 3611-5.
30. [30] Wu J, Bostrom P, Sparks LM, et al. Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human. Cell 2012; 150(2): 366-76.
31. [31] Sharp LZ, Shinoda K, Ohno H, et al. Human BAT Possesses Molecular Signatures That Resemble Beige/Brite Cells. Plos One 2012; 7(11).
32. [32] Lidell ME, Betz MJ, Leinhard OD, et al. Evidence for two types of brown adipose tissue in humans. Nat Med 2013: 19(5): 631-4.
33. [33] Withers SB, Agabiti-Rosei C, Livingstone DM, et al. Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol 2011; 31(4): 908-13.
34. [34] Chang L, Milton H, Eitzman DT, Chen YE. Paradoxical Roles of Perivascular Adipose Tissue in Atherosclerosis and Hypertension. Circ J 2013; 77(1): 11-8.
35. [35] Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84(3): 767-801.
36. [36] Barandier C, Montani JP, Yang ZH. Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. Am J Physiol Heart Circ Physiol 2005; 289(5): H1807-H1813.
37. [37] Takaoka M, Suzuki H, Shioda S, et al. Endovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue. Arterioscler Thromb Vasc Biol 2010; 30(8): 1576-82.
38. [38] Takaoka M, Nagata D, Kihara S, et al. Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling. Circ Res 2009; 105(9): 906-11.
39. [39] Gil-Ortega M, Stucchi P, Guzman-Ruiz R, et al. Adaptative Nitric Oxide Overproduction in Perivascular Adipose Tissue during Early Diet-Induced Obesity. Endocrinology 2010; 151(7): 3299-306.
40. [40] Marchesi C, Ebrahimian T, Angulo O, Paradis P, Schiffrin EL. Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome. Hypertension 2009; 54(6): 1384-92.
41. [41] Galvez B, de Castro J, Herold D, et al. Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 2006; 26(6): 1297-302.
42. [42] Lu C, Su LY, Lee RM, Gao YJ. Alterations in perivascular adipose tissue structure and function in hypertension. Eur J Pharmacol 2011; 656(1-3): 68-73.
43. [43] Zeng ZH, Zhang ZH, Luo BH, et al. The Functional Changes of the Perivascular Adipose Tissue in Spontaneously Hypertensive Rats and the Effects of Atorvastatin Therapy. Clin Exp Hypertens 2009; 31(4): 355-63.
44. [44] Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 1991; 13(2): 277-96.
45. [45] Lohn M, Dubrovska G, Lauterbach B, et al. Periadventitial fat releases a vascular relaxing factor. Faseb J 2002; 16(9): 1057-63.
46. [46] Verlohren S, Dubrovska G, Tsang SY, et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44(3): 271-6.
47. [47] Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007; 151(3): 323-31.
48. [48] Maenhaut N, Van de Voorde J. Effect of hypoxia in mice mesenteric arteries surrounded by adipose tissue. Acta Physiol (Oxf) 2011; 203(1): 235-44.
49. [49] Schleifenbaum J, Kohn C, Voblova N, et al. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. J Hypertens 2010; 28(9): 1875-82.
50. [50] Gao YJ, Zeng ZH, Teoh K, et al. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 2005; 130(4): 1130-6.
51. [51] Maenhaut N, Boydens C, Van de Voorde J. Hypoxia enhances the relaxing influence of perivascular adipose tissue in isolated mice aorta. Eur J Pharmacol 2010; 641(2-3): 207-12.
52. [52] Lee YC, Chang HH, Chiang CL, et al. Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation 2011; 124(10): 1160-71.
53. [53] Lohn M, Dubrovska G, Lauterbach B, et al. Periadventitial fat releases a vascular relaxing factor. Faseb Journal 2002; 16(9): 1057-63.
54. [54] Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) 2006; 231(3): 237-51.
55. [55] Ketonen J, Shi J, Martonen E, Mervaala E. Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57BI/6 mice. Circ J 2010; 74(7): 1479-87.
56. [56] Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320(6061): 454-6.
57. [57] Adamczak M, Wiecek A, Funahashi T, et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003; 16(1): 72-5.
58. [58] Cooper D, Stokes KY, Tailor A, Granger DN. Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc Toxicol 2002; 2(3): 165-80.
59. [59] Fesus G, Dubrovska G, Gorzelniak K, et al. Adiponectin is a novel humoral vasodilator. Cardiovasc Res 2007; 75(4): 719-27.
60. [60] Greenstein AS, Khavandi K, Withers SB, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119(12): 1661-70.
61. [61] Knudson JD, Payne GA, Borbouse L, Tune JD. Leptin and Mechanisms of Endothelial Dysfunction and Cardiovascular Disease. Curr Hypertens Rep 2008; 10(6): 434-9.
62. [62] Lee RMKW, Lu C, Su LY, Gao YJ. Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens 2009; 27(4): 782-90.
63. [63] Lu C, Zhao AX, Gao YJ, Lee RM. Modulation of vein function by perivascular adipose tissue. Eur J Pharmacol 2011; 657(1-3): 111-6.
64. [64] Fang LP, Zhao J, Chen Y, et al. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertens 2009; 27(11): 2174-85.
65. [65] Feng XJ, Chen Y, Zhao J, et al. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun 2009; 380(1): 153-9.
66. [66] Yang GD, Wu LY, Jiang B, et al. H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322(5901): 587-90.
67. [67] Fang LP, Zhao J, Chen Y, et al. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertens 2009; 27(11): 2174-85.
68. [68] Lee YC, Chang HH, Chiang CL, et al. Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation 2011; 124(10): 1160-71.
69. [69] Takir S, Uydes-Dogan BS, Ozdemir O. Retina evokes biphasic relaxations in retinal artery unrelated to endothelium, K(V), K(ATP), K(Ca) channels and methyl palmitate. Microvasc Res 2011; 81(3): 295-302.
70. [70] Withers SB, Agabiti-Rosei C, Livingstone DM, et al. Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol 2011; 31(4): 908-13.
71. [71] Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8(11): 1288-95.
72. [72] Eringa EC, Bakker W, Smulders YM, et al. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 2007; 14(4-5): 389-402.
73. [73] Payne GA, Bohlen HG, Dincer UD, Borbouse L, Tune JD. Periadventitial adipose tissue impairs coronary endothelial function via PKC-beta-dependent phosphorylation of nitric oxide synthase. Am J Physiol Heart Circ Physiol 2009; 297(1): H460-H465.
74. [74] Lu C, Su LY, Lee RM, Gao YJ. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur J Pharmacol 2010; 634(1-3): 107-12.
75. [75] Gao YJ, Takemori K, Su LY, et al. Perivascular adipose tissue promotes vasoconstriction: The role of superoxide anion. Cardiovasc Res 2006; 71(2): 363-73.
76. [76] Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature 2008; 453(7196): 783-7.
77. [77] de Ferranti S, Mozaffarian D. The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54(6): 945-55.
78. [78] Britton KA, Fox CS. Ectopic Fat Depots and Cardiovascular Disease. Circulation 2011; 124(24): E837-E841.
79. [79] Gao YJ, Holloway AC, Zeng ZH, et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res 2005; 13(4): 687-92.
80. [80] Handa P, Tateya S, Rizzo NO, et al. Reduced Vascular Nitric Oxide-cGMP Signaling Contributes to Adipose Tissue Inflammation During High-Fat Feeding. Arterioscler Thromb Vasc Biol 2011; 31(12): 2827-35.
81. [81] Rebolledo A, Rebolledo OR, Marra CA, et al. Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue. Cardiovasc Diabetol 2010; 9(1): 65.
82. [82] Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56(4): 901-11.
83. [83] Maenhaut N, Boydens C, Van de Voorde J. Hypoxia enhances the relaxing influence of perivascular adipose tissue in isolated mice aorta. Eur J Pharmacol 2010; 641(2-3): 207-12.
84. [84] Meijer RI, Serne EH, Smulders YM, et al. Perivascular Adipose Tissue and Its Role in Type 2 Diabetes and Cardiovascular Disease. Curr Diab Rep 2011; 11(3): 211-7.
85. [85] Sacks HS, Fain JN. Human epicardial fat: what is new and what is missing? Clin Exp Pharmacol Physiol 2011; 38(12): 879-87.
86. [86] Nishimura S, Manabe I, Nagasaki M, et al. CD8(+) effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15(8): 914-U116.
87. [87] Okamoto E, Couse T, De Leon H, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 2001; 104(18): 2228-35.
88. [88] Falk E, Thim T, Kristensen IB. Atherosclerotic Plaque, Adventitia, Perivascular Fat, and Carotid Imaging. JACC Cardiovasc Imaging 2009; 2(2): 183-6.
89. [89] Henrichot E, Juge-Aubry CE, Pernin AS, et al. Production of chemokines by perivascular adipose tissue -A role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005; 25(12): 2594-9.
90. [90] Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29(6): 251-5.
91. [91] Baker AR, da Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1.
92. [92] Mahabadi AA, Reinsch N, Lehmann N, et al. Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: A segment analysis. Atherosclerosis 2010; 211(1): 195-9.
93. [93] Wang TD, Lee WJ, Shih FY, et al. Association of epicardial adipose tissue with coronary atherosclerosis is region-specific and independent of conventional risk factors and intra-abdominal adiposity. Atherosclerosis 2010; 213(1): 279-87.
94. [94] Souza DSR, Johansson B, Bojo L, et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: Results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 2006; 132(2): 373-8.
95. [95] Verhagen SN, Visseren FLJ. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011; 214(1): 3-10.
96. [96] Bartelt A, Bruns OT, Reimer R, et al. Brown adipose tissue activity controls triglyceride clearance. Nature Medicine 2011; 17(2): 200-U93.
97. [97] Lee RMKW, Ding LL, Lu C, Su LY, Gao YJ. Alteration of perivascular adipose tissue function in angiotensin II-induced hypertension. Can J Physiol Pharmacol 2009; 87(11): 944-53.
98. [98] Farmer SR. Molecular determinants of brown adipocyte formation and function. Genes Dev 2008; 22(10): 1269-75.
99. [99] Huang F, Lezama MAR, Ontiveros JAP, Hong E. Effect of Losartan on Vascular Function in Fructose-Fed Rats: the Role of Perivascular Adipose Tissue. Clin Exp Hypertens 2010; 32(2): 98-104.
100. [100] Duan SZ, Ivashchenko CY, Whitesall SE, et al. Hypotension, lipodystrophy, and insulin resistance in generalized PPAR gamma-deficient mice rescued from embryonic lethality. J Clin Invest 2007; 117(3): 812-22.